You are here

Dr. Jeff Leiden Is Honored with New England Venture Capital Association’s IMPACT Award

Jeff recognized for his contributions to New England’s innovation economy

Leaders from our innovation ecosystem congratulate Jeff on his award

While honoring New England’s healthcare and technology leaders at the 5th annual NEVY Awards, Dr. Jeffrey Leiden, Chairman, President and CEO of Vertex, was awarded the IMPACT Award for his lifetime of contributions to entrepreneurship and innovation in Boston and across Massachusetts.  

For more than 30 years, Jeff has dedicated his career to improving the lives of people with serious diseases. His work spans all aspects of the biomedical innovation ecosystem, from his early days in academia as a molecular biologist and practicing cardiologist, to his leadership at a life sciences venture capital firm committed to supporting innovative biotech companies.

Since becoming CEO in 2012, Jeff has lead a number of initiatives and investments aimed at advancing Massachusetts as a world leader in life sciences and healthcare, including:

  • Science, technology, engineering and math (STEM) education. Jeff established our comprehensive STEM program to engage and inspire the next generation of scientific leaders. Through this program, thousands of Boston Public Schools students have participated in hands-on learning opportunities in our Learning Lab, mentorship experiences, internships and scholarship programs.
  • Digital Health. Jeff lead the public-private partnership responsible for launching the Digital Healthcare initiative in 2016 aimed at making Massachusetts the world leader in digital healthcare technologies that will transform human health. 

Additionally, as the chair of the Scientific Advisory Board of the Brigham and Women’s Hospital, a member of the Scientific Advisory Board of Boston Children’s Hospital, and a member of the board of fellows of Harvard Medical School, Jeff actively supports and has helped shape innovative research at some of the world’s top teaching and research institutions.